WebDec 28, 2012 · The CaG regimen was as follows: gemcitabine 1000 mg/m 2 (on Days 1, 8 and 15) and carboplatin area under the curve (AUC) = 5 (on Day 2) for a 21-day cycle. All patients treated with MVAC and CaG routinely administered metoclopramide hydrochloride as an antiemetic agent. WebBoth chemo drugs are hard on the bone marrow & kidneys--they both cause neuropathy & can cause hearing loss. The carboplatin is a little more gentle on the kidneys so you …
Managing Bladder Cancer: Chemotherapy Ineligibility Compared …
WebBackground: There are currently no guideline recommendations regarding the treatment of cisplatin-ineligible, clinically lymph node–positive (cN+) bladder... DOAJ is a unique … WebApr 8, 2024 · Poorly differentiated neuroendocrine carcinoma (NEC) of the bladder (BNEC) is a rare type of bladder cancer, summing up to less than 1% of bladder malignancies [].The neuroendocrine component can be found either alone, mostly with small-cell or large-cell morphology, or can be mixed to an epithelial component (mixed adeno … the problem of drug addiction
Treatment patterns and clinical outcomes of chemotherapy
WebJan 27, 2024 · Urothelial cancer of the bladder, renal pelvis, ureter, and other urinary organs is the fifth most common cancer in the United States, and systemic platinum-based chemotherapy remains the standard of care for first-line treatment of advanced/metastatic urothelial carcinoma (UC). Until recently, there were very limited options for patients who … WebManagement of metastatic bladder cancer in the elderly. Cisplatin-based combination chemotherapy is recommended as first-line systemic therapy for patients with metastatic BC based on a relative risk of nearly 50%. 44 The combination of methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) was compared with the doublet of gemcitabine and ... WebOct 14, 2024 · The key difference between carboplatin and cisplatin is that carboplatin shows less consistent survival advantages, whereas cisplatin shows more consistent survival advantages in meta-analyses of … the problem of eusebius